Categories Earnings, Technology
Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, on Friday reported a net loss for the second quarter of 2024, reflecting a decline in revenues.
- Net revenue came in at $1.03 billion in the December quarter, which is down 10% from the prior year quarter
- The company reported a net loss of $204 million or $1.12 per share for the second quarter, compared to earnings of $81 million or $0.44 per share in Q2 2023
- On an adjusted basis, loss per share was $0.24 in Q2, vs. a profit of $0.67 per share a year earlier
- Q2 adjusted EBITDA fell 56% from last year to $124 million as reported, and dropped 57% in constant currency
- During the quarter, Catalent raised $600 million in term loans and used the proceeds to pay down debt
- Recently, the company agreed to be acquired by Novo Holdings an all-cash deal that values it at $16.5 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%